Nigel Sheail

Nigel Sheail has more than 30 years of experience in Global BioPharma Executive leadership. Mr. Sheail dedicated his time in BioPharma to mergers and acquisitions, business development, and licensing, and as a global controller and finance director.

Mr. Sheail served as the Global Head of Mergers & Acquisitions and Business Development & Licensing at Novartis AG since September 2017 and joined Novartis in 2015 as Head of Business Development & Licensing. Prior to Novartis, Mr. Sheail served as the Global Head of Business Development and Licensing at Bayer Healthcare AG. Before serving at Bayer Healthcare AG, Nigel Sheail was Global Head of Licensing and Head of Corporate M&A at F. Hoffman-La Roche Ltd. Additionally, Mr. Sheail has also worked at GSK plc.